Beta-adrenergic agonist

Results: 51



#Item
11Page 1 of 94  INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY CHEMISTRY AND HUMAN HEALTH DIVISION†  IUPAC GLOSSARY OF TERMS USED IN

Page 1 of 94 INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY CHEMISTRY AND HUMAN HEALTH DIVISION† IUPAC GLOSSARY OF TERMS USED IN

Add to Reading List

Source URL: iupac.org

Language: English - Date: 2015-01-13 12:02:23
12HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BETOPTIC S® safely and effectively. See full prescribing information for BETOPTIC S®. BETOPTIC S® (betaxolol hydr

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BETOPTIC S® safely and effectively. See full prescribing information for BETOPTIC S®. BETOPTIC S® (betaxolol hydr

Add to Reading List

Source URL: ecatalog.alcon.com

Language: English - Date: 2014-05-06 21:38:29
137-02-IAEA-CN[removed]Montes-Nino-Spain [Compatibility Mode]

7-02-IAEA-CN[removed]Montes-Nino-Spain [Compatibility Mode]

Add to Reading List

Source URL: www-pub.iaea.org

Language: English - Date: 2014-11-14 04:01:03
14Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MA[removed]Tel[removed]News Release Contact:

Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MA[removed]Tel[removed]News Release Contact:

Add to Reading List

Source URL: www.sunovion.com

Language: English - Date: 2014-10-22 16:40:47
15ARTICLES  Age and Risks of FDA–Approved Long-Acting ␤2-Adrenergic Receptor Agonists AUTHORS: Ann W. McMahon, MD, MS,a Mark S. Levenson, PhD,b Bradley W. McEvoy, DrPH,b Andrew D. Mosholder,

ARTICLES Age and Risks of FDA–Approved Long-Acting ␤2-Adrenergic Receptor Agonists AUTHORS: Ann W. McMahon, MD, MS,a Mark S. Levenson, PhD,b Bradley W. McEvoy, DrPH,b Andrew D. Mosholder,

Add to Reading List

Source URL: pediatrics.aappublications.org

Language: English
16U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

Add to Reading List

Source URL: www.fda.gov

Language: English
17Microsoft PowerPoint - Q-Top 10 Questions_April 8.pptx

Microsoft PowerPoint - Q-Top 10 Questions_April 8.pptx

Add to Reading List

Source URL: www.fda.gov

Language: English
18Respiratory Distress History Asthma; COPD -- chronic bronchitis, emphysema, congestive heart failure Home treatment (oxygen,

Respiratory Distress History Asthma; COPD -- chronic bronchitis, emphysema, congestive heart failure Home treatment (oxygen,

Add to Reading List

Source URL: www.ncems.org

Language: English - Date: 2009-06-29 13:55:32
19With such gains, however, is the potential for illicit use in animals—such as fish, goats, and sheep—for which ractopamine approval hasn’t been granted by the U.S. Food and Drug Administration. “Beta-adrenergic,

With such gains, however, is the potential for illicit use in animals—such as fish, goats, and sheep—for which ractopamine approval hasn’t been granted by the U.S. Food and Drug Administration. “Beta-adrenergic,

Add to Reading List

Source URL: www.ars.usda.gov

Language: English - Date: 2004-04-02 09:12:30
20COMMONWEALTH OF KENTUCKY CABINET FOR HEALTH AND FAMILY SERVICES DEPARTMENT FOR MEDICAID SERVICES PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE MEETING Capital Annex - Room[removed]Capital Avenue

COMMONWEALTH OF KENTUCKY CABINET FOR HEALTH AND FAMILY SERVICES DEPARTMENT FOR MEDICAID SERVICES PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE MEETING Capital Annex - Room[removed]Capital Avenue

Add to Reading List

Source URL: chfs.ky.gov

Language: English - Date: 2014-11-28 08:37:57